NDC 69729-051 – Tenalif Multi Symptom Relief
Acetaminophen 500 mg/20mL; Phenylephrine Hydrochloride 10 mg/20mL; Dextromethorphan Hydrobromide 26.66 mg/20mL; Guaifenesin 400 mg/20mL · Syrup · Oral
Product NDC69729-051
Product details
- Brand name
- Tenalif Multi Symptom Relief
- Generic name
- Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
- Labeler
- OPMX LLC
- Dosage form
- Syrup
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- September 18, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist; alpha-1 Adrenergic Agonist
Active ingredients
- Acetaminophen 500 mg/20mL
- Phenylephrine Hydrochloride 10 mg/20mL
- Dextromethorphan Hydrobromide 26.66 mg/20mL
- Guaifenesin 400 mg/20mL
Uses, dosage, side effects and warnings for Tenalif Multi Symptom Relief →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69729-051-06 | 1 BOTTLE, PLASTIC in 1 CARTON (69729-051-06) / 177 mL in 1 BOTTLE, PLASTIC | Sep 18, 2023 |